Trial · NCT01637623
Results by group57
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 57
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Losartan | Baseline | -0.54 | Standard Deviation 0.29 | bursts/minute*%SaO2 |
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Allopurinol | Baseline | -0.84 | Standard Deviation 0.47 | bursts/minute*%SaO2 |
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Placebo | Baseline | -0.71 | Standard Deviation 0.43 | bursts/minute*%SaO2 |
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Losartan | Following 6 weeks of therapy | -0.69 | Standard Deviation .50 | bursts/minute*%SaO2 |
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Allopurinol | Following 6 weeks of therapy | -0.66 | Standard Deviation 0.38 | bursts/minute*%SaO2 |
| Change in Muscle Sympathetic Nerve Activity Responses During Hypoxia | Placebo | Following 6 weeks of therapy | -0.61 | Standard Deviation 0.40 | bursts/minute*%SaO2 |
| Change in Aortic Pulse Wave Velocity | Losartan | -0.6 | 95% Confidence Interval -1.0 to -0.2 | m/s | |
| Change in Aortic Pulse Wave Velocity | Allopurinol | -0.03 | 95% Confidence Interval -0.5 to 0.4 | m/s | |
| Change in Aortic Pulse Wave Velocity | Placebo | 0.2 | 95% Confidence Interval -0.3 to 0.7 | m/s | |
| Cerebrovascular Conductance | Losartan | baseline | 0.32 | Standard Deviation 0.13 | cm/sec/mmHg |
| Cerebrovascular Conductance | Allopurinol | baseline | 0.27 | Standard Deviation 0.97 | cm/sec/mmHg |
| Cerebrovascular Conductance | Placebo | baseline | 0.33 | Standard Deviation 0.11 | cm/sec/mmHg |
| Cerebrovascular Conductance | Losartan | After six weeks treatment | 0.36 | Standard Deviation 0.14 | cm/sec/mmHg |
| Cerebrovascular Conductance | Allopurinol | After six weeks treatment | 0.31 | Standard Deviation 0.12 | cm/sec/mmHg |
| Cerebrovascular Conductance | Placebo | After six weeks treatment | 0.34 | Standard Deviation 0.12 | cm/sec/mmHg |
| Forearm Vascular Conductance | Losartan | baseline | 0.41 | Standard Deviation 0.21 | ml/min^-1 dL^-1 mmHg^-1 |
| Forearm Vascular Conductance | Allopurinol | baseline | 0.43 | Standard Deviation 0.2 | ml/min^-1 dL^-1 mmHg^-1 |
| Forearm Vascular Conductance | Placebo | baseline | 0.49 | Standard Deviation 0.31 | ml/min^-1 dL^-1 mmHg^-1 |
| Forearm Vascular Conductance | Losartan | After 6 weeks of treatment | 0.42 | Standard Deviation 0.17 | ml/min^-1 dL^-1 mmHg^-1 |
| Forearm Vascular Conductance | Allopurinol | After 6 weeks of treatment | 0.55 | Standard Deviation 0.31 | ml/min^-1 dL^-1 mmHg^-1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01637623/results